Standardized Weaning from Temporary Extracorporeal Life Support in Cardiovascular Patients.


Journal

The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 18 6 2019
medline: 15 12 2020
entrez: 18 6 2019
Statut: ppublish

Résumé

Separation from extracorporeal life support (ECLS) is often based on individual decisions rather than evaluated standard operating procedures (SOPs). Therefore, we strived to evaluate a SOP, summarizing specific treatment paths for this group of patients. A total of 107 cardiovascular patients were supported with ECLS within a 4-year period. Fifty-three patients were treated before the SOP was introduced (group A) and 54 patients were treated afterward (group B). Patient characteristics and outcomes were analyzed and compared between the two time periods regarding baseline characteristics, compliance with SOP criteria, and the end points successful weaning and 30-day survival. Successful weaning rose significantly from 56.6 to 74.1% ( The SOP for ECLS weaning showed higher weaning rates compared with a weaning based on individual decisions. Although only parts of the SOP were associated with higher weaning and survival rates, the SOP was experienced as a useful guideline for standardized ECLS management.

Identifiants

pubmed: 31207648
doi: 10.1055/s-0039-1692177
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

425-432

Informations de copyright

Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

Dr. Trummer reports personal fees from Resuscitec GmbH, outside the submitted work. All other authors have no conflict of interest.

Auteurs

Marie Thomas (M)

Department for Cardiovascular Surgery, Universitäts-Herzzentrum Freiburg Bad Krozingen GmbH, Freiburg, Baden-Württemberg, Germany.

Maximilian Kreibich (M)

Department for Cardiovascular Surgery, Universitäts-Herzzentrum Freiburg Bad Krozingen GmbH, Freiburg, Baden-Württemberg, Germany.

Friedhelm Beyersdorf (F)

Department for Cardiovascular Surgery, Universitäts-Herzzentrum Freiburg Bad Krozingen GmbH, Freiburg, Baden-Württemberg, Germany.

Christoph Benk (C)

Department for Cardiovascular Surgery, Universitäts-Herzzentrum Freiburg Bad Krozingen GmbH, Freiburg, Baden-Württemberg, Germany.

Sven Maier (S)

Department for Cardiovascular Surgery, Universitäts-Herzzentrum Freiburg Bad Krozingen GmbH, Freiburg, Baden-Württemberg, Germany.

Georg Trummer (G)

Department for Cardiovascular Surgery, Universitäts-Herzzentrum Freiburg Bad Krozingen GmbH, Freiburg, Baden-Württemberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH